financetom
Business
financetom
/
Business
/
Paramount to become exclusive US home for UFC in $7.7 billion rights deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Paramount to become exclusive US home for UFC in $7.7 billion rights deal
Aug 11, 2025 10:27 AM

(Reuters) -Skydance-owned Paramount will become the exclusive U.S. home of Ultimate Fighting Championship under a seven-year media rights deal valued at about $7.7 billion, marking the first major strategic move by the merged media giant under new CEO David Ellison.

Starting next year, Paramount+ will carry the complete U.S. slate of 13 numbered UFC events and 30 Fight Nights. UFC, owned by TKO Group Holdings, will also have select numbered cards simulcast on Paramount's CBS broadcast network, the companies announced on Monday.

The deal builds on Ellison's commitment to increase investment in high-quality exclusive content, which he had called the "single biggest driver of subscriber growth".

Sports content, has become the cornerstone of media strategy, as cord-cutting accelerates, with rivals such as Netflix and Disney also striking similar deals to strengthen their offerings.

Netflix secured a $5 billion, 10-year global deal for WWE Raw from 2025 and added two NFL Christmas Day games. Disney's ESPN extended rights with NFL, NHL, MLB and College Football Playoff.

"The addition of UFC's year-round must-watch events to our platforms is a major win," Ellison said, calling UFC a "global sports powerhouse".

Paramount will pay an average of $1.1 billion a year to TKO Group and include events at no extra cost to subscribers, shifting away from UFC's traditional pay-per-view model. It may seek UFC rights in other markets as they come up for bidding.

"They are not playing for near-term earnings outperformance, they are trying to create a long-term imprint on the future of the media industry to 'win,'" LightShed Partners analysts said.

UFC stages about 43 live events a year, reaching roughly 100 million U.S. fans and nearly 950 million households globally. Its slate includes marquee-numbered card events like UFC 300, and weekly Fight Nights.

Paramount and Skydance completed their $8.4 billion merger last week, capping a drawn-out deal process marked by political scrutiny and shareholder concerns.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Greenwich Lifesciences Insider Bought Shares Worth $380,945, According to a Recent SEC Filing
Greenwich Lifesciences Insider Bought Shares Worth $380,945, According to a Recent SEC Filing
Mar 7, 2024
06:52 AM EST, 03/07/2024 (MT Newswires) -- Snehal Patel, 10% Owner, Director, CEO and CFO, on March 05, 2024, executed a purchase for 30,500 shares in Greenwich Lifesciences ( GLSI ) for $380,945. Following the Form 4 filing with the SEC, Patel has control over a total of 5,343,777 shares of the company, with 5,343,777 shares held directly. SEC Filing:...
Nvidia Insider Sold Shares Worth $170,020,366, According to a Recent SEC Filing
Nvidia Insider Sold Shares Worth $170,020,366, According to a Recent SEC Filing
Mar 7, 2024
06:48 AM EST, 03/07/2024 (MT Newswires) -- Tench Coxe, Director, on March 05, 2024, sold 200,000 shares in Nvidia ( NVDA ) for $170,020,366. Following the Form 4 filing with the SEC, Coxe has control over a total of 3,787,612 shares of the company, with 5,228 shares held directly and 3,782,384 shares controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1045810/000122520824003814/xslF345X03/doc4.xml ...
Cigna launches program to help clients manage rising costs due to weight loss drug boom
Cigna launches program to help clients manage rising costs due to weight loss drug boom
Mar 7, 2024
March 7 (Reuters) - Cigna ( CI ) on Thursday announced its unit is launching a financial guarantee program to help companies and other clients manage the rising drugs expenses associated with using GLP-1 weight loss and diabetes drugs. ...
GSK Reports Positive Results From Interim Analysis of Test of Potential Blood Cancer Treatment -- Shares Up Pre-Bell
GSK Reports Positive Results From Interim Analysis of Test of Potential Blood Cancer Treatment -- Shares Up Pre-Bell
Mar 7, 2024
06:51 AM EST, 03/07/2024 (MT Newswires) -- GSK (GSK) said Thursday that it had received positive results from an interim analysis of a late-stage study of its potential multiple myeloma treatment Blenrep in combination with pomalidomide plus dexamethasone compared with bortezomib plus dexamethasone. The company said the trial, involving 302 patients, met its primary endpoint of progression-free survival at a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved